These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3149344)

  • 21. Interferon therapy for chronic viral hepatitis.
    di Bisceglie AM
    N Engl J Med; 1994 Jan; 330(2):137-8. PubMed ID: 8259170
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
    Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
    J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response].
    Fedorchenko SV; Vovk AD; Rybalko SL
    Ter Arkh; 1994; 66(2):24-9. PubMed ID: 8160138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
    Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic type C hepatitis with alpha interferon.
    Hoofnagle JH; Di Bisceglie AM
    Semin Liver Dis; 1989 Nov; 9(4):259-63. PubMed ID: 2513647
    [No Abstract]   [Full Text] [Related]  

  • 27. [Development of chronic non-A, non-B hepatitis and transition to liver cirrhosis].
    Kiyosawa K; Akahane Y; Yamamura N; Koike Y; Sodeyama T; Furuta S
    Nihon Rinsho; 1981 Oct; 39(10):3242-50. PubMed ID: 6803022
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Hattori H; Mikuriya S; Mamiya T; Hatano K; Shiina T; Yamada T
    Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of chronic non-A, non-B hepatitis with recombinant interferon alfa and factors that influence the response to the treatment].
    Serejo F; Ramalho F; Marinho R; Raimundo M; Velosa J; de Moura MC
    Acta Med Port; 1991; 4(6):288-92. PubMed ID: 1807091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of viral hepatitis C].
    Pawlotsky JM; Marcellin P; Trépo C; Dhumeaux D
    Gastroenterol Clin Biol; 1994; 18(4):362-73. PubMed ID: 7958653
    [No Abstract]   [Full Text] [Related]  

  • 31. [Histological evaluation of the liver and response to interferon in chronic hepatitis C].
    Yoshida H; Iwabuchi S; Murayama M; Uchikoshi T
    Nihon Rinsho; 1994 Jul; 52(7):1763-8. PubMed ID: 8078200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coinfection of hepatitis C virus and hepatitis G virus in patients with chronic hepatitis].
    Oshita M; Mita E; Hayashi N
    Nihon Rinsho; 1997 Mar; 55(3):617-20. PubMed ID: 9086769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic hepatitis of viral etiology].
    Loginov AS; Blok IuE
    Ter Arkh; 1988; 60(2):3-7. PubMed ID: 3130674
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary evaluation of intratumoral injection of a Streptococcus pyrogenes preparation in patients with malignant brain tumors.
    Tanaka R; Sekiguchi K; Suzuki Y; Sobue H; Ueki K
    Cancer; 1980 Oct; 46(7):1688-94. PubMed ID: 6998559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of intratumoral injection of an immunopotentiator (OK-432) in patients with hepatocellular carcinoma].
    Imaoka S; Sasaki Y; Matsui Y; Ishikawa O; Taniguchi K; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1982 Oct; 17(7):1957-62. PubMed ID: 6298326
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppression of hepatitis C virus RNA by interferon-alpha.
    Kanai K; Iwata K; Nakao K; Kako M; Okamoto H
    Lancet; 1990 Jul; 336(8709):245. PubMed ID: 1973789
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prolonged (24 weeks) treatment of chronic hepatitis type B with recombinant interferon-alpha].
    Matsuda H; Kashiwagi T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):629-34. PubMed ID: 12442457
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of immunopotentiator on six patients with HBeAg positive chronic hepatitis (author's transl)].
    Kosaka Y; Tameda Y; Nishimura A; Fujimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Aug; 78(8):1675. PubMed ID: 7321268
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon treatment of chronic non-A, non-B (HCV) hepatitis: the saga continues.
    Koff RS
    Gastroenterology; 1990 May; 98(5 Pt 1):1384-6. PubMed ID: 2108893
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy.
    Thomson BJ; Doran M; Lever AM; Webster AD
    Lancet; 1987 Mar; 1(8532):539-41. PubMed ID: 2434816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.